Immune assay for monitoring response to oncolytic vaccinia virus and uses thereof
KR20200101065A
Oncolytic virus guiding immune cell or antibody therapeutics, the immune cells specific for the antigen induced by the virus, and combination therapy using thereof
WO2019151836A1
Oncolytic vaccinia virus expressing an immune checkpoint protein antagonist to treat cancer
US2020085891A1
Oncolytic vaccinia virus and checkpoint inhibitor combination therapy
EP3347460A1
Modified oncolytic vaccinia viruses expressing a cytokine and a car- boxylesterase and methods of use thereof
CA2990133A1
Compositions and methods for viral embolization
KR20140123436A
Novel oncolytic virus HBB301 derived from vaccinia virus
KR20140122601A
Host cell transformed by polynucleopeptide coding the interferon activation suppression protein to produce vaccinia virus
KR20140122603A
Host cell transformed by polynucleopeptide coding the protein related to forming extracellular enveloped vaccinia virus
KR20140122604A
Transformed host cell to produce vacccinia virus, method for preparing the same and method for producing of vaccinia virus using the same
